Stock listing
OMND Stock Price, News, Filings & Events — Optimind Pharma Corp.
Selected listing: OMND · CSE · CAD · CA
This page tracks Optimind Pharma Corp.'s OMND:CSE listing on CSE in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following OMND:CSE. OMND:CSE is the stock-level entry point for investors researching Optimind Pharma Corp., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Optimind Pharma Corp. (Ticker: OMND) is a public company listed in Canada with a market capitalization of approximately CAD 367,053.58. The company focuses on developing innovative pharmaceutical solutions. Investors can find detailed information about its operations and performance on its corporate page.

- Ticker
- OMND:CSE
- Asset type
- Stock
- Market cap
- $372,727
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- CSE
- Currency
- CAD
Optimind Pharma Corp. OMND:CSE stock context
This page tracks Optimind Pharma Corp.'s OMND:CSE listing on CSE in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following OMND:CSE. OMND:CSE is the stock-level entry point for investors researching Optimind Pharma Corp., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Optimind Pharma Corp. (Ticker: OMND) is a public company listed in Canada with a market capitalization of approximately CAD 367,053.58. The company focuses on developing innovative pharmaceutical solutions. Investors can find detailed information about its operations and performance on its corporate page.
Latest news from Optimind Pharma Corp.
Optimind Pharma Announces Adoption of Semi-Annual Reporting
July 24, 2026
Optimind Pharma Announces Definitive Agreement for Proposed Change of Business with InterviewDesk
September 8, 2025
Optimind Pharma Announces Termination of Letter of Intent
September 4, 2025
Optimind Pharma Enters into Letter of Intent with Monjin to Acquire AI Business
March 24, 2025
Optimind Pharma Closes Second Tranche of Private Placement
July 29, 2024
Research Optimind Pharma Corp.
Optimind Pharma Corp. investor report
Review AI stock analysis and investor report context for OMND:CSE.
Optimind Pharma Corp. company profile
View the public company page for Optimind Pharma Corp. on 6ix.
Optimind Pharma Corp. news
Read company news and market updates connected to Optimind Pharma Corp..
Optimind Pharma Corp. investor events
Find investor webinars, events, and replay context for Optimind Pharma Corp..